Kloka, Jan
Friedrichson, Benjamin
Dauth, Stephanie
Foldenauer, Ann Christina
Bulczak-Schadendorf, Anita
Vehreschild, Maria J. G. T.
Matos, Francisco Maio
Riera-Mestre, Antoni
van Asselt, Antoinette D. I.
De Robertis, Edoardo
Juskeviciene, Vilma Traskaite
Meybohm, Patrick
Tomescu, Dana
Lacombe, Karine
Stehouwer, Coen D. A.
Zacharowski, Kai https://orcid.org/0000-0002-0212-9110
,
Old, Oliver
Ketomaeki, Markus
Grebe, Lea
Booms, Patrick
Lindau, Simone
Zinn, Sebastian
Maushagen, Isabel
Wolf, Timo
Stephan, Christoph
Weynants, Cathy
Daamen, Sylvia
Wülfroth, Petra
Steiner, Thomas
van Hulst, Marinus
Kranke, Peter
Hottenrott, Sebastian
Schlesinger, Tobias
Schmid, Benedikt
Röder, Daniel
Kranke, Eva
Haas, Tobias
Schlesinger, Philipp
Sitter, Magdalena
Valeri, Davide
Iglesias, Raquel Torres
Mora-Luján, José María
Iriarte, Adriana
Cerdà, Pau
Vaguliene, Neringa
Macas, Andrius
Litviniene, Jolanta
Balne, Kristina
Monteiro, Catarina
Ferreira, Inês Antunes
Couceiro, Patrícia
Soares, Pedro
Beirão, Sofia
Aad, Yasmine Abi
Chiarabini, Thibault
Popescu, Mihai
van der Kallen, C. J. H.
Funding for this research was provided by:
HORIZON EUROPE Framework Programme (grant agreement No 101045956)
Johann Wolfgang Goethe-Universität, Frankfurt am Main
Article History
Received: 23 June 2022
Accepted: 29 July 2022
First Online: 19 August 2022
Declarations
:
: Study protocol V1.1 (EudraCT no. 2021-005059-35), patient information, and informed consent were approved by the Ethics Committee of the University of Frankfurt, Germany (Ref: 2021-512-AMG, Chair: Prof. Dr. Harder) and of all participating centres on 18 February 2022. At the same time, the study documents have been approved by the responsible federal authority (Bundesinstitut für Arzneimittel und Medizinprodukte – No. 61-3910-4045190) according to the requirements of §42 Abs. 2 AMG and §9 GCP-V. Each patient must give written informed consent to participate in the study.
: Not applicable.
: KZ is PI of the projects ENVISION and COVend, which have received funding from the European Union’s Horizon 2020 and Horizon Europe research and innovation programmes, respectively, under grant agreement no. 101015930 (ENVISION) and no. 101045956 (COVend). All other authors declare that they have no competing interests.